Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.
Marvaso G, Vischioni B, Jereczek-Fossa BA, Ciardo D, Fossati P, Giandini T, Morlino S, Carrara M, Romanelli P, Russi E, Valvo F, Valdagni R, Orecchia R. Marvaso G, et al. Among authors: ciardo d. Radiol Med. 2017 Feb;122(2):140-145. doi: 10.1007/s11547-016-0699-1. Epub 2016 Oct 21. Radiol Med. 2017. PMID: 27770265
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM).
Giandini T, Tenconi C, Carrara M, Ciocca M, Russo S, Panaino CMV, Cattani F, Ciardo D, Morlino S, Avuzzi B, Bedini N, Villa S, Marvaso G, Romanelli P, Hasegawa A, Vischioni B, Valvo F, Jereczek-Fossa BA, Orecchia R, Valdagni R, Pignoli E. Giandini T, et al. Among authors: ciardo d. Tumori. 2017 Sep 18;103(5):430-437. doi: 10.5301/tj.5000654. Epub 2017 Jul 8. Tumori. 2017. PMID: 28708234
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G, Jereczek-Fossa BA, Vischioni B, Ciardo D, Giandini T, Hasegawa A, Cattani F, Carrara M, Ciocca M, Bedini N, Villa S, Morlino S, Russo S, Zerini D, Colangione SP, Panaino CMV, Fodor C, Santoro L, Pignoli E, Valvo F, Valdagni R, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: ciardo d. Tumori. 2017 May 12;103(3):314-318. doi: 10.5301/tj.5000587. Epub 2016 Dec 2. Tumori. 2017. PMID: 28009421 Clinical Trial.
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach.
Marvaso G, Jereczek-Fossa BA, Riva G, Bassi C, Fodor C, Ciardo D, Cambria R, Pansini F, Zerini D, De Marco P, Cattani F, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: ciardo d. Clin Genitourin Cancer. 2017 Jun;15(3):376-383. doi: 10.1016/j.clgc.2017.01.007. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28190704 Clinical Trial.
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Jereczek-Fossa BA, Surgo A, Maisonneuve P, Maucieri A, Gerardi MA, Zerini D, Marvaso G, Ciardo D, Volpe S, Rojas DP, Riva G, Alessandro O, Dicuonzo S, Fanetti G, Romanelli P, Starzyńska A, Cattani F, Cambria R, Fodor C, Garibaldi C, Romanò C, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: ciardo d. Radiol Med. 2019 Jan;124(1):65-78. doi: 10.1007/s11547-018-0937-9. Epub 2018 Sep 15. Radiol Med. 2019. PMID: 30219945
Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Jereczek-Fossa BA, Surgo A, Maisonneuve P, Maucieri A, Gerardi MA, Zerini D, Marvaso G, Ciardo D, Volpe S, Rojas DP, Riva G, Alessandro O, Dicuonzo S, Fanetti G, Romanelli P, Starzyńska A, Cattani F, Cambria R, Fodor C, Garibaldi C, Romanò C, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: ciardo d. Radiol Med. 2020 Jan;125(1):107. doi: 10.1007/s11547-019-01086-w. Radiol Med. 2020. PMID: 31591702
Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300).
Gugliandolo SG, Marvaso G, Comi S, Pepa M, Romanò C, Zerini D, Augugliaro M, Russo S, Vischioni B, Valvo F, Giandini T, Avuzzi B, Valdagni R, Ciardo D, De Cobelli O, Jereczek-Fossa BA, Cattani F, Orecchia R. Gugliandolo SG, et al. Among authors: ciardo d. Phys Med. 2020 Aug;76:327-336. doi: 10.1016/j.ejmp.2020.07.012. Epub 2020 Aug 2. Phys Med. 2020. PMID: 32750548
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparison.
Cambria R, Ciardo D, Bazani A, Pansini F, Rondi E, Maestri D, Zerini D, Marvaso G, Romanelli P, Timon G, Fodor C, Petralia G, Alessi S, Pricolo P, Vischioni B, Fossati P, Molinelli S, Russo S, Ciocca M, De Cobelli O, Renne G, Orecchia R, Cattani F, Jereczek-Fossa BA. Cambria R, et al. Among authors: ciardo d. Tumori. 2022 Jun;108(3):263-269. doi: 10.1177/03008916211011667. Epub 2021 Apr 25. Tumori. 2022. PMID: 33896239
83 results